TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 216 filers reported holding TG THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.63 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $186 | -66.4% | 22,300 | 0.0% | 0.00% | -66.7% |
| Q2 2023 | $554 | +199.5% | 22,300 | +81.3% | 0.00% | +200.0% |
| Q1 2023 | $185 | -99.8% | 12,300 | -28.5% | 0.00% | 0.0% |
| Q3 2022 | $102,000 | +39.7% | 17,200 | 0.0% | 0.00% | – |
| Q2 2022 | $73,000 | -65.4% | 17,200 | -22.5% | 0.00% | -100.0% |
| Q1 2022 | $211,000 | -50.0% | 22,200 | 0.0% | 0.00% | -50.0% |
| Q4 2021 | $422,000 | -42.9% | 22,200 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $739,000 | -14.2% | 22,200 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $861,000 | -15.3% | 22,200 | +5.2% | 0.00% | -33.3% |
| Q1 2021 | $1,017,000 | -7.4% | 21,100 | 0.0% | 0.01% | -14.3% |
| Q4 2020 | $1,098,000 | +94.3% | 21,100 | 0.0% | 0.01% | +75.0% |
| Q3 2020 | $565,000 | -31.3% | 21,100 | -50.0% | 0.00% | +33.3% |
| Q2 2020 | $822,000 | – | 42,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 5,229,619 | $74,261,000 | 3.55% |
| RA Capital Management | 2,472,344 | $35,107,000 | 2.69% |
| SENZAR ASSET MANAGEMENT, LLC | 475,918 | $6,758,000 | 2.13% |
| BRIDGER MANAGEMENT, LLC | 2,373,920 | $33,710,000 | 2.04% |
| Opaleye Management Inc. | 274,200 | $3,893,000 | 1.11% |
| Virtus ETF Advisers LLC | 89,920 | $1,277,000 | 1.11% |
| Eversept Partners, LP | 150,000 | $2,130,000 | 0.99% |
| Ghost Tree Capital, LLC | 300,000 | $4,260,000 | 0.86% |
| PURA VIDA INVESTMENTS, LLC | 50,000 | $710,000 | 0.42% |
| HIGHLAND CAPITAL MANAGEMENT LP | 464,391 | $6,595,000 | 0.34% |